Kinnate is a biopharmaceutical company advancing a pipeline of precision oncology therapeutics to treat patients with genomically. Founded in 2018, Kinnate Biopharma is backed by investors that include Eshelman Ventures, Foresite Capital, Nextech Invest, OrbiMed, and Vida Ventures and is headquartered in San Diego.
FOUNDED:
2018
INDUSTRY:
Biotechnology
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
